People · Operator
Named in public records as an officer, director or promoter · active 2020–2020 · Other, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cybin Inc. | — | Other | Series D+ | $200.8M | $871K | 2020 |
| Neurotez Inc. | — | Pharmaceuticals | Seed | $2.0M | $76.1M | 2020 |
Jukka Karjalainen at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jukka Karjalainen on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| James Harris | 1 | 10 |
| Eric So | 1 | 5 |
| John Kanakis | 1 | 4 |
| Mark Lawson | 1 | 4 |
| Douglas Drysdale | 1 | 2 |
| Doug Drysdale | 1 | 2 |
| Theresa Firestone | 1 | 2 |
| Greg Cavers | 1 | 2 |
| Eric Hoskins | 1 | 2 |
| George Tziras | 1 | 2 |
| Paul Glavine | 1 | 2 |
| George Perry | 1 | 2 |
| Hamish McArthur | 1 | 1 |
| Thomas Humphries | 1 | 1 |
| Jane Johnston | 1 | 1 |
| John Wesson Ashford | 1 | 1 |
| Bob Oliver | 1 | 1 |
| Gabriel Fahel | 1 | 1 |
| Aaron Bartlone | 1 | 1 |
| Grant Froese | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.